# Patients With Vulvovaginal Candidiasis

> **NCT03024502** · PHASE1,PHASE2 · UNKNOWN · sponsor: **University of Sao Paulo** · enrollment: 90 (estimated)

## Conditions studied

- Vulvovaginal Candidiasis

## Interventions

- **DRUG:** EPP-AF Gel 1%
- **DRUG:** EPP-AF Gel 2%
- **DRUG:** Clotrimazole

## Key facts

- **NCT ID:** NCT03024502
- **Lead sponsor:** University of Sao Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-01-30
- **Primary completion:** 2020-01
- **Final completion:** 2020-06
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2018-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03024502

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03024502, "Patients With Vulvovaginal Candidiasis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03024502. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*